CPT codes

53947 CPT codes with hospital pricing data in the network.

• CPT 81172 — AFF2 GEN ALYS CHARAC ALLELES (545 hospitals, — samples)
• CPT 81174 — AR (androgen receptor) (eg, spinal and bulbar muscular atrophy, Kennedy disease, X chromosome inactivation) gene analysis; known familial variant (547 hospitals, — samples)
• CPT 81176 — ASXL1 GENE TARGET SEQ ALYS (570 hospitals, — samples)
• CPT 81186 — CACNA1A GEN KNOWN FAMIL VRNT (545 hospitals, — samples)
• CPT 81188 — CSTB GENE DETC ABNOR ALLELE (544 hospitals, — samples)
• CPT 81190 — Cstb gene known famil vrnt (544 hospitals, — samples)
• CPT 81212 — BRCA1&2 185&5385&6174 VRNT (611 hospitals, — samples)
• CPT 81221 — CFTR (cystic fibrosis transmembrane conductance regulator) (eg, cystic fibrosis) gene analysis; known familial variants (620 hospitals, — samples)
• CPT 81237 — EZH2 (enhancer of zeste 2 polycomb repressive complex 2 subunit) (eg, diffuse large B-cell lymphoma) gene analysis, common variant(s) (eg, codon 646) (556 hospitals, — samples)
• CPT 81238 — F9 FULL GENE SEQUENCE (595 hospitals, — samples)
• CPT 81239 — Dmpk gene charac alleles (548 hospitals, — samples)
• CPT 81248 — G6PD (glucose-6-phosphate dehydrogenase) (eg, hemolytic anemia, jaundice), gene analysis; known familial variant(s) (544 hospitals, — samples)
• CPT 81258 — HBA1/HBA2 GENE FAM VRNT (549 hospitals, — samples)
• CPT 81262 — IGH GENE REARRANG DIR PROBE (584 hospitals, — samples)
• CPT 81283 — IFNL3 (interferon, lambda 3) (eg, drug response), gene analysis, rs12979860 variant (657 hospitals, — samples)
• CPT 81285 — FXN GENE CHARAC ALLELES (544 hospitals, — samples)
• CPT 81289 — Fxn gene known famil variant (546 hospitals, — samples)
• CPT 81303 — MECP2 GENE KNOWN VARIANT (567 hospitals, — samples)
• CPT 81316 — PML/RARALPHA 1 BREAKPOINT (564 hospitals, — samples)
• CPT 81328 — SLCO1B1 (solute carrier organic anion transporter family, member 1B1) (eg, adverse drug reaction), gene analysis, common variant(s) (eg, *5) (618 hospitals, — samples)
• CPT 81333 — TGFBI (transforming growth factor beta-induced) (eg, corneal dystrophy) gene analysis, common variants (eg, R124H, R124C, R124L, R555W, R555Q) (544 hospitals, — samples)
• CPT 81337 — SMN1 GEN NOWN FAMIL SEQ VRNT (546 hospitals, — samples)
• CPT 81341 — TRB@ GENE REARRANGE DIRPROBE (573 hospitals, — samples)
• CPT 81349 — CYTOG ALYS CHRML ABNR LW-PS (525 hospitals, — samples)
• CPT 81362 — HC Hbb Known Familial Variant(S) (552 hospitals, — samples)
• CPT 813T — EGD VOL ADJMT BARIATRIC BALO (85 hospitals, — samples)
• CPT 81417 — Exome (eg, unexplained constitutional or heritable disorder or syndrome); re-evaluation of previously obtained exome sequence (eg, updated knowledge or unrelated condition/syndrome) (555 hospitals, — samples)
• CPT 81427 — GENOME RE-EVALUATION (544 hospitals, — samples)
• CPT 81433 — HC HRDTRY BRST CA-RLATD DSORDRS (458 hospitals, — samples)
• CPT 81436 — Hereditary colon cancer disorders (eg, Lynch syndrome, PTEN hamartoma syndrome, Cowden syndrome, familial adenomatosis polyposis); duplication/deletion analysis panel, must include analysis of at leas (471 hospitals, — samples)
• CPT 81437 — Hereditary neuroendocrine tumor-related disorders (eg, medullary thyroid carcinoma, parathyroid carcinoma, malignant pheochromocytoma or paraganglioma), genomic sequence analysis panel, 5 or more gene (602 hospitals, — samples)
• CPT 81438 — Hereditary neuroendocrine tumor disorders (eg, medullary thyroid carcinoma, parathyroid carcinoma, malignant pheochromocytoma or paraganglioma); duplication/deletion analysis panel, must include analy (456 hospitals, — samples)
• CPT 81458 — SO GSAP DNA CPY NMBR&MCRSTL (536 hospitals, — samples)
• CPT 81462 — SO GSAP CLL FR DNA/DNA&RNA (523 hospitals, — samples)
• CPT 81463 — So gsap cl fr cpy nmbr&mcrst (520 hospitals, — samples)
• CPT 81464 — SO GSAP CLL FR MCRSTL INS (521 hospitals, — samples)
• CPT 81471 — X-linked intellectual disability (XLID) (eg, syndromic and non-syndromic XLID); duplication/deletion gene analysis, must include analysis of at least 60 genes, including ARX, ATRX, CDKL5, FGD1, FMR1, (555 hospitals, — samples)
• CPT 81493 — COR ARTERY DISEASE MRNA (558 hospitals, — samples)
• CPT 814T — PRQ NJX BIOD OSTEO MATRL FEM (85 hospitals, — samples)
• CPT 81504 — ONCOLOGY TISSUE OF ORIGIN (543 hospitals, — samples)
• CPT 81506 — ENDO ASSAY SEVEN ANAL (544 hospitals, — samples)
• CPT 81509 — Fetal congenital abnormalities, biochemical assays of three proteins (PAPP-A, hCG ºany form», DIA), utilizing maternal serum, algorithm reported as a risk score (548 hospitals, — samples)
• CPT 81510 — FTL CGEN ABNOR THREE ANAL (582 hospitals, — samples)
• CPT 81512 — Fetal congenital abnormalities, biochemical assays of five analytes (AFP, uE3, total hCG, hyperglycosylated hCG, DIA) utilizing maternal serum, algorithm reported as a risk score (560 hospitals, — samples)
• CPT 81518 — Oncology (breast), mRNA, gene expression profiling by real-time RT-PCR of 11 genes (7 content and 4 housekeeping), utilizing formalin-fixed paraffin-embedded tissue, algorithms reported as percentage (533 hospitals, — samples)
• CPT 81520 — ONC BREAST MRNA 58 GENES (575 hospitals, — samples)
• CPT 81521 — Oncology (breast), mRNA, microarray gene expression profiling of 70 content genes and 465 housekeeping genes, utilizing fresh frozen or formalin-fixed paraffin-embedded tissue, algorithm reported as i (541 hospitals, — samples)
• CPT 81528 — Oncology (colorectal) screening, quantitative real-time target and signal amplification of 10 DNA markers (KRAS mutations, promoter methylation of NDRG4 and BMP3) and fecal hemoglobin, utilizing stool, algorithm reported as a positive or negative result (555 hospitals, — samples)
• CPT 81535 — Oncology (gynecologic), live tumor cell culture and chemotherapeutic response by DAPI stain and morphology, predictive algorithm reported as a drug response score; first single drug or drug combinatio (551 hospitals, — samples)
• CPT 81536 — Oncology gynecologic (551 hospitals, — samples)